Cantitate/Preț
Produs

Down Syndrome and Alzheimer's Disease

Autor Vee Prasher
en Limba Engleză Paperback – 15 iul 2006
This is the first book in the field to address the underlying biological abnormalities of Dementia in Alzheimer’s Disease (DAD) in people with Down syndrome. It brings together research findings relating to the neuropathology, genetics, blood markers and neurophysiology of Alzheimer’s disease in older adults with Down syndrome. Down Syndrome and Alzheimer’s Disease presents vital information to medical professionals who provide clinical care to people with Alzheimer’s disease and Down syndrome. It will also be of great benefit to researchers with an interest in Alzheimer’s disease and Down syndrome and academics researching ageing issues in people with Down Syndrome. It complements Alzheimer's Disease and Dementia in Down Syndrome and Intellectual Disabilities by the same author.
Citește tot Restrânge

Preț: 29021 lei

Preț vechi: 34885 lei
-17% Nou

Puncte Express: 435

Preț estimativ în valută:
5557 5786$ 4610£

Comandă specială

Livrare economică 24 ianuarie-07 februarie

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781857756371
ISBN-10: 1857756371
Pagini: 200
Dimensiuni: 152 x 229 x 13 mm
Greutate: 0.43 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:United Kingdom

Public țintă

Professional Reference

Cuprins

Overview of Alzheimer’s disease in Down syndrome. Neuropathology of Alzheimer’s disease in Down syndrome. Genetics, Alzheimer’s disease and Down syndrome. Amyloid beta and tau Proteins in Alzheimer’s disease and Down syndrome. Down syndrome, dementia, and superoxide dismutase. Macrocytosis: a peripheral marker for dementia in Alzheimer’s disease in adults with Down syndrome? Thyroid function, dementia and Down syndrome. Neurophysiological changes associated with dementia in Down syndrome. Neuroimaging studies of persons with Down syndrome. Concluding remarks

Descriere

This is the first book in the field to address the underlying biological abnormalities of Dementia in Alzheimer’s Disease (DAD) in people with Down syndrome